Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
Beximco Pharmaceuticals Limited
BXPBeximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh. Address: 19 Dhanmondi R/A, Dhaka, Bangladesh, 1205
Analytics
WallStreetin tavoitehinta
11 434.12 GBXP/E-suhde
3.875Osinkotuotto
9.2 %Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut BXP
Osinkoanalytiikka BXP
Osinkojen kasvu 5 vuoden aikana
45 %Jatkuva kasvu
–Maksusuhde 5 vuoden keskiarvo
39 %Osinkohistoria BXP
Osakkeen arvostus BXP
Talousasiat BXP
Tuloksia | 2019 | Dynamiikka |